IDH1 and astrocytoma (excluding glioblastoma): Regarding the WHO grade, grade 2 accounted for 93 (56.7%) cases of IDH mutant and 1p/19q codeleted oligodendrogliomas and 122 (48.4%) cases of IDH mutant astrocytomas.